Terbinafine in onychomycosis with involvement by non‐dermatophytic fungi

@article{Nolting1994TerbinafineIO,
  title={Terbinafine in onychomycosis with involvement by non‐dermatophytic fungi},
  author={S. Nolting and M. Brautigam and G. Weidinger},
  journal={British Journal of Dermatology},
  year={1994},
  volume={130}
}
Sixty‐five patients with onychomycosis involving the yeasts Candida albicans or C. parapsilosis, or the mould Scopulariopsis brevicaulis, were treated for up to 48 weeks with terbinafine 250 mg daily. At the end of therapy mycological and clinical cure rates were 70% and 54% for C.albicans, and 85% and 63% for C. parapsilosis, respectively. Three out of seven S. brevicaulis infections were cured. Within 6 months of therapy, relapses occurred in 45.5% of the cured patients in the case of C… Expand
Treatment of Candida nail infection with terbinafine.
TLDR
The administration of terbinafine for 16 weeks is effective in the treatment of Candida nail infection and Liver enzyme values should be determined during the first month of treatment. Expand
Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study
TLDR
For the first time with this disease, total cure was observed even in imidazole‐refractory patients or chronic cases (47·2% with a lesion present for longer than 10 years); the efficacy of terbinafine in Cladosporium carnonii‐infected patients seemed higher, as indicated by the examination at 4 months. Expand
ONYCHOMYCOSIS TREATED WITH A SHORT COURSE OF ORAL TERBINAFINE
TLDR
The study was designed as an open, nonrandomized, uncontrolled clinical trial, and patients with a confirmed clinical and mycologic diagnosis of onychomycosis were referred from the dermatology outpatient clinic. Expand
Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?
Onychomycosis of the nails includes fungal infection caused by primary nail pathogens that invade the healthy nail plate and secondary invasion in nails with preexisting disease. Onychomycosis may beExpand
Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.
TLDR
Itraconazole appears to be effective and safe for the treatment of toenail onychomycosis caused by some nondermatophyte molds alone or in combination with dermatophytes. Expand
A multicentre trial of terbinafine in patients with chromoblastomycosis: Effect on clinical and biological criteria
TLDR
A multicentre, pilot clinical trial of terbinafine was performed on 35 patients with active chromoblastomycosis to evaluate its potential as a novel therapy for this fungal disorder and for the first time in this disease, total cure was observed in imidazole-refractory patients and chronic cases. Expand
Terbinafine (Lamisilr`) in the treatment of onychomycosis
TLDR
Several double-blind, parallel-group studies comparing terbinafine with griseofulvin, itraconazole and fluconazole in the treatment of onychomycosis in both toenail and fingernail disease have shown that terbINAfine is significantly more efficacious, as well as cost-effective. Expand
Management of Onychomycoses
TLDR
The clinical presentation of onychomycosis is at best indicative of fungal infection, and the growth of a credible pathogen is an indispensable prerequisite for definite diagnosis, and cure cannot be expected for every case. Expand
Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
  • Aditya K. Gupta
  • Medicine
  • Journal of the American Podiatric Medical Association
  • 2002
TLDR
It was concluded that ciclopirox 8% nail lacquer, which has recently become available in the larger size of 6.6 mL, is a cost-effective agent for the management of toenail onychomycosis. Expand
The role of nondermatophyte molds in onychomycosis: diagnosis and treatment
TLDR
Better, faster, and cheaper methods of identifying etiologic agents, investigations as to how to demonstrate nail invasion, and studies to determine treatment efficacy, outcome, and necessity are needed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Treatment of onychomycosis with terbinafine
TLDR
Terbinafine was generally well tolerated: the most frequent drug‐related adverse events were mild‐to‐moderate gastrointestinal disturbances and changes in liver or renal biochemical tests were not considered clinically relevant. Expand
Short term treatment of dermatophyte onychomycosis with terbinafine.
TLDR
12 weeks' terbinafine is effective and safe treatment for nail dermatophytosis. Expand
A randomized treatment duration‐finding study of terbinafine in onychomycosis
TLDR
Oral treatment with terbinafine is effective and generally well tolerated in patients with onychomycosis, and a treatment period of 12 weeks is sufficient. Expand
Treatment of dermatomycoses with topically applied allylamines: naftifine and terbinafine
Two examples of antifungal drugs belonging to the newly developed class of drugs referred to as allylamines have been evaluated for their efficacy, tolerability and pharmacokinetic profile when usedExpand
Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum
Summary: Over 4000 cases of fungal nail, sole and palm infection recorded during a three‐year study period were investigated to determine the prevalence and significance of etiologic agents otherExpand
A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize.
TLDR
It appears that both griseofulvin and ketoconazole can eradicate the episode of onychomycosis, and the use of ketconazole in long-term therapy may result in serious side effects and should be considered carefully prior to treatment. Expand
Enteric candidiasis. Diagnosis and clinical considerations.
TLDR
The presence of oral and/or cutaneous candidiasis in a patient with diarrhea furnishes a clinical clue to probable candidal etiology of the enteritis. Expand
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
TLDR
Preliminary findings indicate that itraconazole may hold promise for the prophylaxis of opportunistic fungal infections in patients at risk, for example women with chronic recurrent vaginal candidiasis, immunodeficient patients with chronic mucocutaneous candidiasis and patients receiving immunosuppressant drugs. Expand
Studies of the invasive, mycelial form of Candida albicans.
TLDR
By fluorescent microscopy, and by special staining methods, it was shown that ribo-nucleic acid is present throughout the entire length of C. albicans hyphae and is concentrated at the septa and hyphal tip, which supports the view that C.Albicans forms true mycelium and suggests that the mycelial formation may help the fungus to inva... Expand
Inhibitory Effect of Antifungal Agents on Germ Tube Formation in Candida albicans. Hemmeffekt antifungaler Wirkstoffe auf die Keimschlauchbildung von Candida albicans
Summary: The allylamine derivatives naftifine and terbinafine were compared in vitro with 15 standard antifungals in terms of their inhibitory effects on the yeast‐mycelial (Y‐M) transformation inExpand
...
1
2
3
4
...